Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$506,118
-$52,198 QoQ
Shares Held
4,006
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,366
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZEVIN ASSET MANAGEMENT LLC holds $59,856,217 across 9 Drug Manufacturers - General names. GILD ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
76,892 | $19,349,102 | |
| 2 | LLY |
ELI LILLY & Co
|
12,300 | $14,752,990 | |
| 3 | NVS |
Novartis AG
|
74,291 | $11,642,885 | |
| 4 | AZN |
Astrazeneca PLC
|
58,678 | $11,126,522 | |
| 5 | AMGN |
Amgen Inc
|
3,256 | $1,179,062 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,318 | $683,363 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
4,006 | $506,118 | |
| 8 | PFE |
Pfizer Inc
|
14,641 | $352,555 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $506,118 | 4,006 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $558,316 | 4,006 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $491,696 | 4,006 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $444,666 | 4,006 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $444,145 | 4,006 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $594,425 | 5,305 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $556,252 | 6,022 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $504,465 | 6,017 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $412,826 | 6,017 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $440,745 | 6,017 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $489,057 | 6,037 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $450,913 | 6,017 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $463,730 | 6,017 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $697,777 | 8,410 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $721,998 | 8,410 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $518,812 | 8,410 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $519,822 | 8,410 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $499,974 | 8,410 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $610,650 | 8,410 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $587,438 | 8,410 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $579,112 | 8,410 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $543,538 | 8,410 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $489,966 | 8,410 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $360,814 | 5,710 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $439,327 | 5,710 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $410,058 | 5,485 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||